Pfizer Inc to Acquire Trillium Therapeutics Inc Call Transcript
Good day, everyone, and welcome to Pfizer's Analyst and Investor Call to discuss proposed acquisition of Trillium Therapeutics Inc. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo, Senior Vice President and Chief Investor Relations Officer. Please go ahead, sir.
Thank you, Sylvia. Good morning, everyone, and thank you for joining us on short notice. It's my pleasure to be welcoming you to a call to discuss our acquisition of Trillium today. Turn to Slide 2, please. As you can see on the screen, we will be making forward-looking statements during the call regarding amongst other topics, our anticipated future operating and financial performance, business plans and prospects and expectations for our product pipeline and marketed products, which are subject to risks and uncertainties as well as the use of non-GAAP financial information.
Additional information regarding forward-looking statements and our non-GAAP financial measures is
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |